chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My first COVID vaccine injection was December 19, 2020 (10-month postpartum) and my 2nd was January 9, 2021 (11 months postpartum). Symptoms started 3 months after my 2nd vaccine (04/11/21). Extremely heavy irregular periods in between my normal periods. Menstrual cycle is typical 28 days. I am having very heavy periods starting 13 days into my cycle that lasts 7 days. Also having periods when I should be at the 28th day of my cycle. So essentially I'm bleeding every 13-21 days. I am on Junel birth control which I started (04/24). I was on Lo Loestrin at the time of the vaccines.
I started to notice slight ringing in my ears soon after getting my second vaccine shot. About a week later. This condition has progressively gotten worse. The ringing is louder now. I have now realized it?s called tinnitus.
lndividual Suddenly passed away on 3/7/21.....His Psychiartrist stated that there could be an adverse effect with COVID, the COVID Vaccination and medications, with an emphasis on Clozapine
Had Moderna Covid vaccine 1/21. 3 days later she had nausea and dry heaves, cough, & clear rhinorrhea. The next day she had a fever, Max 101, poor appetite and nausea. Fever last 3 days, then went away. Still having fatigue 1 week out
Tinnitus symptoms increase noticeably and interfere with normal activity including sleep, reading, and concentration one week after vaccination. Prior to vaccination tinnitus symptoms were known and managed, typically did not interfere with normal activity.  Other symptoms occurring concurrently with increase in tinnitus include tiredness and slight headache. Note that I also received a flu vaccination on the same date.
2nd dose given 59 days after the 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (2nd dose given 59 days after the 1st dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (2nd dose given 59 days after the 1st dose). On 30-Mar-2021, PRODUCT DOSE OMISSION ISSUE (2nd dose given 59 days after the 1st dose) had resolved.            For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown), the reporter did not provide any causality assessments.  The reporter was calling on behalf of their mother. The reporter mentioned that the patient received their first dose of the Moderna Covid-19 vaccine on 30-Jan-2021. The pharmacy did not get the vaccine supply for their 2nd dose. The patient received their second dose on 30-Mar-2021, 59 days after the 1st dose.   No Concomitant product use was reported. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.
While patient was waiting after receiving her AFLURIA shot, approx 10 min she complained of a tingling to nose. I gave her some of BENADRYL and observed her another 5 min. She showed no signs of anaphylaxis (swelling, DIB) I asked patient if she wanted an ambulance, she declined and said she would proceed to Emerg. on her own across the street from our pharmacy. The Dr. called me 10 min later said they gave her an EPIPEN & steroids no other signs of anaphylaxis and would be releasing her.
Still has a little bump from the first dose at the vaccination site; A little diarrhea; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Still has a little bump from the first dose at the vaccination site), DIARRHOEA (A little diarrhea) and FATIGUE (Fatigue) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     Concomitant products included LIRAGLUTIDE (VICTOZA), METFORMIN, LOSARTAN, CLOPIDOGREL and ROSUVASTATIN for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (Still has a little bump from the first dose at the vaccination site), DIARRHOEA (A little diarrhea) and FATIGUE (Fatigue). At the time of the report, VACCINATION SITE MASS (Still has a little bump from the first dose at the vaccination site) had not resolved and DIARRHOEA (A little diarrhea) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported.
I experienced a significant headache; sore injection site; This is a spontaneous report from a contactable other hcp (Patient). A 27-years-old female patient received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: FC3183), via an unspecified route of administration, administered in Arm Right on 07Sep2021 15:15 (at the age of 27-years-old) as DOSE 1, SINGLE for COVID-19 immunisation. Medical history and concomitant medications were not reported. known allergies was reported as No. It was reported that she was not a pregnant at the time of vaccination. She did not take any other vaccine in four weeks prior COVID -19 vaccine. List of any other medications the patient received within 2 weeks of vaccination was reported as no. She was not diagnosed with COVID prior vaccination and not tested with COVID post vaccination. Within the first 24 hours, on 07Sep2021 21:00 patient experienced a significant headache. Upon waking the next morning, it was gone. No sore arm, but sore injection site for 24-48 hrs afterwards. Treatment received for events was reported as no. The outcome of event significant headache recovered on 08Sep2021 and outcome of sore injection site was recovered on unspecified date in Sep2021. Follow-up attempts are completed. No further information is expected.
last 6 months a lot of brain fog/ She is now 6 months past the 2nd dose and she still has a lot of brain fog; my memory issues got worse/ just feels like my memory is going; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (last 6 months a lot of brain fog/ She is now 6 months past the 2nd dose and she still has a lot of brain fog) and MEMORY IMPAIRMENT (my memory issues got worse/ just feels like my memory is going) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 002B21A) for COVID-19 vaccination.     The patient's past medical history included Back surgery. Concurrent medical conditions included Cold sores, Urinary tract disorder, Fibromyalgia, Arthritis, Muscle pain, Sleep apnea and Lipoma. Concomitant products included AMOXICILLIN for Back surgery, VALACICLOVIR HYDROCHLORIDE (VALTREX) for Cold sores, PREGABALIN (LYRICA) for Fibromyalgia and Arthritis, ARNICA MONTANA for Muscle pain, OXYGEN for Sleep apnea, TROSPIUM CHLORIDE for Urinary tract disorder, CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), CALCIUM, COLECALCIFEROL (VITAMIN D3), ASCORBIC ACID (VITAMIN C PLUS [ASCORBIC ACID]), LISINOPRIL, LORAZEPAM (ATIVAN), DONEPEZIL HYDROCHLORIDE (ARICEPT), ESCITALOPRAM OXALATE (LEXAPRO), QUETIAPINE FUMARATE (SEROQUEL), ATORVASTATIN, FISH OIL and TIOTROPIUM BROMIDE MONOHYDRATE (SPIRIVA) for an unknown indication.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced FEELING ABNORMAL (last 6 months a lot of brain fog/ She is now 6 months past the 2nd dose and she still has a lot of brain fog) and MEMORY IMPAIRMENT (my memory issues got worse/ just feels like my memory is going). The patient was treated with DONEPEZIL HYDROCHLORIDE (ARICEPT) for Adverse event, at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (last 6 months a lot of brain fog/ She is now 6 months past the 2nd dose and she still has a lot of brain fog) had not resolved and MEMORY IMPAIRMENT (my memory issues got worse/ just feels like my memory is going) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication details also included centrum silver, breo and albuterol for unknown indication. Patient reported that she got her EKG and bloodwork done for the surgery. The patient took  20-30 seconds to remember where she got her EKG and bloodwork done.
Post vax, the pt developed cellulitis. The full upper arm was involved. The pt sought unspecified medical attention.
Patient had itchiness & redness. BP 116/78; HR 70; RR 18.  Given Benadryl and symptoms improved.  Pt deemed stable and released from vaccination site
Breakthrough case admission after 2 vaccines Pfizer 3/3/21 Lot# EN6202;  Pfizer 3/24/21 Lot# EN6204
Pt developed a large erythematous patch over right thigh (site of injection) no induration, area warm and 8 x 8 cm, mild irritability. No fever was noted.
No additional adverse effect reported; the patient received one improperly stored dose of VARIVAX on 3/3/2020; Information has been received from a nurse prescriber, referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided.       On 03-MAR-2020, the patient received one improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot # S028920, expiration date 16-SEP-2021; dose detail, strength and route were unknown) for prophylaxis. The vaccine was exposed to temperature excursion between 6 degrees Fahrenheit to 14 degrees Fahrenheit (5.69 degrees Fahrenheit) for 1 second (incorrect product storage). There was previous temperature excursion between 6 degrees Fahrenheit to 14 degrees Fahrenheit (5.81 degrees Fahrenheit) for 28 minutes. The sterile diluent used to reconstitute the varicella virus vaccine live (oka/merck) (VARIVAX) was stored properly. The call was due to digital data logger. No additional adverse effect was reported.
This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with GARDASIL 9 lot # M013636, expiration date: 15-FEB-2018, intramuscularly route per reporter (strength, dose and frequency were not reported) for prophylaxis, which was improperly stored at 32 and 36 Farenheit degrees for an unknown time. This excursion was detected due to a digital data logger, however no previous temperature excursion was reported. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA010177: US-009507513-1701USA013134: US-009507513-1701USA013139: US-009507513-1701USA013136: US-009507513-1701USA013137: US-009507513-1701USA013138: US-009507513-1701USA013132: US-009507513-1701USA013135.
Body aches, fever, cold sweats, headaches, light headedness (all lasted about 36hrs).
Onset of diarrhea @ 48 hrs, followed by headache, stiff neck.  Doesn't think she had fever.  Was taking Tylenol. Symptoms still present on day 5.
Approximately two weeks post-vaccination, developed slightly raised, red itchy patch around the injection site.  Patch is about the size of a half-dollar or larger, and warm to the touch.
Pt received flu shot at about 12PM: complained of some pain during injection, but no inflammation. Pt called pharmacy at 2pm with tingling/pain in left hand, no injection site pain. Pt advised to take TYLENOL and see MD if necessary. F/u with pt next day, no more tingling but still some pain. Will follow-up with pt in several days-no more pain.
I had what urgent care told me was hives.  The hives were very large and unlike any hives I had ever had.  They covered my neck, went onto my back, chest and stomach.  On my neck they were very large, covering over half my neck for just one, raised, hot to touch, and the color of what i would describe as port wine.  I was prescribed benadryl and prednisone.  I only took benadryl.  I took 3 tablets right away and also the benadryl cream i applied to all the hives.  It took about 24 hours for the hives to completely disappear.
fatigue, imaging suggestive of early infiltrates. O2sat 95%, No cough, no SOB  Treated for pneumonia,IV antibiotics.
Patient received expired vaccine. DH and Pfizer recommend revaccination. Patient was contacted to schedule an appointment. She will decide at a later time .
Sunday night my eyes were a little swollen and hurt when I blink. Monday morning both eyes were very swollen and extremely red, no pain and vision was mor effected.
tongue swelling, chest tightness, felt tightness in the throat An evening later, woke up and had rapid heart beat and felt bad. Had rapid heart beat the following evening
Swelling & pain at injection site ((L) arm), difficulty moving (L) arm, malaise, myalgia, fatigue, dyspnea, headache, flu-like symptoms, mild fever (100 degrees F).
This spontaneous report as received from a licensed practical nurse refers to an unspecified number of patients of unknown age and gender. There was no information about concomitant medication and pertinent medical history reported. On an unknown date, the unspecified number of patients was vaccinated with unspecified doses of improperly stored PROQUAD (route was not reported) lot # K025759, expiry date 08-JUN-2016. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Almost 14 days after injection developed a circle rash near injection area.  No itching or pain associated with it.
After vaccines patient developed redness and swelling of the area, posteriorly developed a white head that developed as an abscess in the area after several weeks. Seen at the ER twice given antibiotics and area drained.
Before walking out of the room, I asked patient if he was ok, nodded and said "yes". 5 minutes post administration, patient fell off the table. Patient stated "didn't know he was on the ground" or "what had happened". BP was taken 100/52. Pt was kept and monitored for an additional 15 mins. Physician was called to assess patient. No c/o pain/HA.
I had J&J shot 3/7/21 originally, and then 1 Moderna booster 11/10/21.  The next morning I felt a tingling sensation in my face and some dental pain, by 11 am I phoned my dr.?s office that I had lost feeling on the right side of my face including my eye and tongue and was told to go to the ED to be evaluated for stroke. In the ED the doctor did not visually examine my face or remove my mask but ran an EKG and MRI and Rx Meloxicam and discharged me with a ?migraine variant? as my cheek was numb to his touch and I had a headache following the MRI but no pain prior.  The numbness continued to increase in my face the following day and,  per my discharge instructions, I followed up with my GP, Dr. one week following my vaccinations. Dr. listened to my symptoms, description of the event, and that while the dr. did not examine my face I did examine my face when I got home and noticed I did not have any wrinkles on the right side of my face, especially the smile line under my nose but it remained prominent on the left side. My forehead felt tight and heavy and lower eye lid dropped Dr. diagnosed with Bells Palsy.
Patient began to feel lightheaded, diaphoretic, vital signs: 94/60, hr 48, saturation 94%. Paramedics called to assess for low heart and low blood pressure.- Patient feeling better, encouraged to call family or friend for drive home, patient insisted on driving self home. Patient encouraged to follow up with primary MD.
The patient was administered lower than authorized dose of the Moderna COVID-19 bivalent booster i.e 0.25 ml instead of 0.5 ml.; No adverse event; This spontaneous case was reported by a physician and describes the occurrence of ACCIDENTAL UNDERDOSE (The patient was administered lower than authorized dose of the Moderna COVID-19 bivalent booster i.e 0.25 ml instead of 0.5 ml.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (The patient was administered lower than authorized dose of the Moderna COVID-19 bivalent booster i.e 0.25 ml instead of 0.5 ml.) and NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (The patient was administered lower than authorized dose of the Moderna COVID-19 bivalent booster i.e 0.25 ml instead of 0.5 ml.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (The patient was administered lower than authorized dose of the Moderna COVID-19 bivalent booster i.e 0.25 ml instead of 0.5 ml.).    No concomitant medications were reported.   It was reported that, nurses had no Standing orders other than what they had for the second booster, when first administering Bivalent boosters. So, they assumed the same dose as the second booster, hence they were administering 0.25 ml instead of 0.5 ml to uncompromised adults.  It was reported that approximately 100 patients were administered an invalid dose  0.25 ml instead of 0.5 ml of the Moderna COVID-19 bivalent booster.  No treatment details were reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-646512 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-646512:Matsre case
overdose; no adverse event; Spontaneous information has been received from the patient's aunt, referring to male patient of unknown age (reported as 1). The patients' medical history, concurrent conditions, drug reactions or allergies and concomitant therapies were not provided.   On an unknown date, the patient received 2 doses of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (dose, route, site, indication, lot # and expiration date were not provided) at the same time instead of getting one dose at the doctor's visit and the coming back for the second dose. The patient's aunt was concerned that this was an overdose, and after finishing the call, the patient's aunt mentioned that the company was going to get sued. No additional adverse event information was reported or product quality complaint reported.
Pt recvd Hep B vax on 5MAY92 & md was able to palpate two by two sunken area @ the inject site was also sl red; pt had a hole in arm where inject was given; muscle atrophy; dx lipoatrophy;
Within an hour, I had a headache and dizziness, which persisted for the remainder of the day. By the next morning, the headache and dizziness were still present and I also had body aches as well as hot/cold flashes, but no fever. This also lasted the entire day and into the following day. It has now been over 72 hours and I am still having dizziness and my head is spinning almost constantly, especially when I move around.
Six day after I received my vaccine I tested positive for COVID. My symptoms were very mild, the sinus infection was much worse.
I had my Shingrix vaccine the day after my Remicade Infusion and a week after that vaccine I started to feel ill and having headaches.  I had begun watching my blood pressure after my second COVID 19 vaccine  on 3/10. After that shot I felt extremely fatigue and then I developed swelling in my feet and hands. My feet stayed swollen for over a month after my COVID vaccine and then my blood pressure rose. On 4/19 I went for my Remicade infusion my blood pressure was slightly elevate. I had my Shingles vaccine the next day and then my blood pressure start to escalate and remained escalated until  I ended up in the ER on  April 26 because my blood pressure was 227/126. I had no blood pressure problems before then.
DAILY CALLS WITH PATIENT ADVICE. TOLD TO GO TO EMERGENCY ROOM IF CONDITION WORSENS. MEDICAL ASSISTANT GAVE 1ML INSTEAD OF 0.5. SHE DID NOT NOTIFY US UNTIL AFTER THE LAST PATIENT WAS GIVEN THE SHOT. SHE OPENED A NEW VIAL TO THE PATIENTS. EMPLOYEE WAS TERMINATED AND WE CONTACTED PATIENTS TO SEE IF THEY WERE FINE AND ADVISED THEM ABOUT GOING TO E.R. IF CONDITION WORSENS. CALLED DAILY TO VERIFY WELL-BEING.
pain in lower back; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (pain in lower back) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (pain in lower back). At the time of the report, BACK PAIN (pain in lower back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   Reporter did not allow further contact
Night of vaccine, pt awoke, complaints of "my throat is closing up." Mom said tonsils were touching uvula and that pt was burning up with fever. No cough, wheeze, abdominal pain or rash. Symptoms resolved in 24 hours.
To ED with c/o recurrent dizziness. Stroke alert called and seen by neurology. CT head (-) for acute event. CTA head and neck without significant stenoses. Tested COVID (+). Asymptomatic and not hypoxic. Incidental finding. Dizziness resolved spontaneously.
patient's birthday would make him 12 at time of vaccination by 2 days.  patient received the pfizer pediatric dose which is indicated for patient's 5-11 years old
9/28/21 pt to ED with cough and fever; tested positive for COVID; CXR showed bilateral pleural effusions and PE in RUL; admitted; O2 supplementation; dexamethasone, Tocilizumab; Eliquis for PE; worsening respiratory status; placed on BiPAP; DNR/DNI; pt passed away in the hospital
Lightheaded when standing or stopped; flush; coughing; tiredness; Lethargic; This is a spontaneous report from a contactable consumer(patient). A 63-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: Not reported) via an unspecified route of administration, administered in right arm on11Mar2021 04:00 PM as DOSE 1, SINGLE for COVID-19 immunization (age at vaccination 63 years). The patients medical history was not reported. Atvastin was taken as concomitant other medications in two weeks for an unspecified reason and an unknown start date and stop date. No other vaccine in four weeks was reported. The patient had Covid prior vaccination. No Covid tested post vaccination. No Known allergies. On 12Mar2021 12:00 PM the patient experienced Lightheaded when standing or stopped, flush, coughing, tiredness, lethargic. No treatment received for the events. The outcome of the event was recovering.  Information about lot/batch number cannot be obtained. No further information expected.
Pt states he passed out & not feeling good.  Diaphoretic. BP 102/67 Via w/c taken to Observation area to lie down.  Feeling cold, tingly all over & "wiped out".  3:25PM Taking juice & crackers.  Still dizzy when tried to stand up.  BP 127/92 3:40PM  Left w/o assistance.  Feeling much better